Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.
Sign Up to like & getrecommendations! Published in 2023 at "Expert opinion on emerging drugs"
DOI: 10.1080/14728214.2023.2209720
Abstract: INTRODUCTION Sjögren's Disease, SjD, is a systemic autoimmune disorder characterized by reduced function of the salivary and lacrimal glands. Patients suffer from dryness, fatigue, and pain and may present with or without extra-glandular organ involvement.… read more here.
Keywords: review; recent phase; phase; phase iii ... See more keywords
Sjögren-related cardiomyopathy presenting with cardiogenic shock
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2021-244451
Abstract: Previous reports have described non-ischaemic cardiomyopathy related to a variety of autoimmune diseases. However, very few case reports describe Sjögren disease as a contributing factor to cardiomyopathy. We report the case of a 69-year-old woman… read more here.
Keywords: related cardiomyopathy; gren disease; cardiogenic shock; gren related ... See more keywords
Dysregulated long non-coding RNA in Sjögren’s disease impacts both interferon and adaptive immune responses
Sign Up to like & getrecommendations! Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002672
Abstract: Objective Sjögren’s disease (SjD) is an autoimmune disease characterised by inflammatory destruction of exocrine glands. Patients with autoantibodies to Ro/SSA (SjDRo+) exhibit more severe disease. Long non-coding RNAs (lncRNAs) are a functionally diverse class of… read more here.
Keywords: cell; non coding; disease; immune ... See more keywords